The American Cancer Society surveyed 488 funded researchers to assess the state of their projects in early April.
Fifty-seven percent of respondents said that their institutions have temporarily halted research, and 59 percent said their institution had closed laboratories.
About 54 said they are working entirely remotely, and 32 percent said they were working mostly remotely with occasional in-person visits to their offices, campuses or labs.
“It is abundantly clear that the COVID-19 pandemic is having a major impact on cancer research,” said William C. Phelps, PhD, senior vice president of extramural research at the American Cancer Society. “In some labs queried for our survey, all nonessential research had been halted, with research on COVID-19 being the only type of research being encouraged.”
More articles on public health:
COVID-19 mortality dips; hospitalizations continue to rise — 4 CDC findings
US coronavirus cases stuck at top of curve
5-year-old dies of mysterious condition potentially linked to COVID-19
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
